We added the following clinical trials to Metastatic Trial Search for April 2025. To see all clinical trials, please visit Metastatic Trial Search.

Triple Negative Trials

• Alpelisib Targeted Therapy with Pembrolizumab Immunotherapy for Metastatic Triple Negative Breast Cancer with Active Brain Metastases
• Low Dose Capecitabine Chemotherapy for People with Advanced HR+, HER2- or Triple Negative Breast Cancer

Other Stage IV Trials

• CLSP-1025 Immunotherapy for Advanced HLA-A*02:01 Positive Breast Cancer with p53 R175H Mutations
• Proton Craniospinal Irradiation for Metastatic Breast Cancer with Leptomeningeal Metastasis
• Radiation to Reduce Side Effects for People with Metastatic Breast Cancer with Leptomeningeal Metastases

Last Modified on April 1, 2025